Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating Epacadostat in combination with Nivolumab in select advanced cancers; results have been posted following completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies
• Colorectal Cancer
• Glioblastoma
• Head and Neck Cancer
• Lung Cancer
• Lymphoma
• Melanoma
• Ovarian Cancer

Drugs mentioned

• Epacadostat (epacadostat)
• nivolumab (nivolumab)

Snippet

Sponsor: Incyte Corporation | Conditions: B-cell Malignancies, Colorectal Cancer (CRC) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-26